You are here

drug discounts

Johnson & Johnson cites rebates and discounts for drug price increases

Johnson & Johnson cites rebates and discounts for drug price increases

Fierce Pharma

Flag link:

AstraZeneca, Novo Nordisk and Sanofi score 340B-related appeals court win over HHS

AstraZeneca, Novo Nordisk and Sanofi score 340B-related appeals court win over HHS

Endpoints

Flag link:

How health systems are responding to 340B discount restrictions

How health systems are responding to 340B discount restrictions

Beckers Hospital Review

Flag link:

Baker's dozen: Pfizer joins 12 peers in restricting sales of discounted drugs under a federal program

Baker's dozen: Pfizer joins 12 peers in restricting sales of discounted drugs under a federal program

Endpoints

Flag link:

Amgen halts some drug discounts for safety net hospitals as SCOTUS takes on 340B case

Amgen halts some drug discounts for safety net hospitals as SCOTUS takes on 340B case

Endpoints

Flag link:

UCB to restrict 340B discounts to hospitals using community pharmacies

UCB to restrict 340B discounts to hospitals using community pharmacies

Beckers Hospital Review

Flag link:

Mixed court decisions for Novartis in DC and Sanofi, Novo Nordisk in NJ further complicate whose interpretation of 340B is correct

Mixed court decisions for Novartis in DC and Sanofi, Novo Nordisk in NJ further complicate whose interpretation of 340B is correct

Endpoints

Flag link:

Eli Lilly serves up a win over Biden's HHS in drug discount court case

Eli Lilly serves up a win over Biden's HHS in drug discount court case

Endpoints

Flag link:

AstraZeneca slammed by advocacy group over drug discount denials

AstraZeneca slammed by advocacy group over drug discount denials

Beckers Hospital Review

Flag link:

Novo Nordisk tackles outcomes and affordability with pilot tying copays to adherence

Novo Nordisk tackles outcomes and affordability with pilot tying copays to adherence

Fierce Pharma

outcomes-based pricing

Flag link:

Payer Power: Why Eli Lilly, Janssen, and Merck Deeply Discount Their Drug Prices

Payer Power: Why Eli Lilly, Janssen, and Merck Deeply Discount Their Drug Prices

Drug Channels

Flag link:

Aetna Will Pass Along Discounts as Drug Price Scrutiny Increases

Aetna Will Pass Along Discounts as Drug Price Scrutiny Increases

Bloomberg

payer discounts

Flag link:

Janssen’s New Transparency Report: A Peek Behind the Drug Pricing Curtain Raises Troubling Questions About Rebates

Janssen’s New Transparency Report: A Peek Behind the Drug Pricing Curtain Raises Troubling Questions About Rebates

Drug Channels

Flag link:

Get ready for a drop in branded drug spending this year, thanks to rebates and discounts: report

Get ready for a drop in branded drug spending this year, thanks to rebates and discounts: report

Fierce Pharma

Flag link:

Drug discounting to insurers soars from 28% to 41% in 5 years, with no end in sight: report

Drug discounting to insurers soars from 28% to 41% in 5 years, with no end in sight: report

Fierce Pharma

Flag link:

Teva scrambles to match 30% Copaxone discounts from Mylan's knockoff: analyst

Teva scrambles to match 30% Copaxone discounts from Mylan's knockoff: analyst

Fierce Pharma

Teva Pharmaceutical

Flag link:

Mylan offered EpiPen discounts to states in exchange for privileged status, documents show

Mylan offered EpiPen discounts to states in exchange for privileged status, documents show

Stat

Flag link:

California bill would end 'purely profit-driven' practice of drug-company coupons

California bill would end 'purely profit-driven' practice of drug-company coupons

LA Times, CA

Flag link:

Medicare patients don’t share in drug discounts given insurers and PBMs

Medicare patients don’t share in drug discounts given insurers and PBMs

Stat

Flag link:

When do pharmas disclose launch prices up front? When they’re pricing at a discount

When do pharmas disclose launch prices up front? When they’re pricing at a discount

Fierce Pharma

Flag link:

Pages